KPKarolina Petraškaitė

Karolina Petraškaitė

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karolina Petraškaitė has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    One-Session Versus Three-Sessions of Virtual Reality Exposure Therapy for Public Speaking Anxiety: Protocol of a Randomized Controlled Trial

    by Goda Gegieckaitė, Olga Zamalijeva, Karolina Petraškaitė, Egle Nagevice, Philip Lindner, Per Carlbring, Tom Van Daele, Gerhard Andersson, Jonas Eimontas

    Background: A 1-session virtual reality (VR) exposure for public speaking anxiety has been found to be effective in reducing public speaking anxiety. Previous meta-analyses comparing 1-session to several sessions of in vivo exposure for specific phobias did not find a difference in effectiveness. However, due to the specificity of VR exposure and public speaking anxiety, it is unclear how dividing the same amount of exposure tasks into 3 shorter sessions instead of one long session would affect the effectiveness of VR exposure for public speaking. Objective: The aim of this study is to compare the efficacy of a VR exposure-based intervention for public speaking anxiety and the level of VR presence between a 1-session treatment and an equal exposure time divided into 3 sessions, followed by 4 weeks of online intervention in both groups. Methods: This randomized controlled trial will aim to recruit 86 higher education students experiencing high levels of public speaking anxiety, who will be randomized into one of two conditions: either 1 or 3 sessions of VR exposure therapy, with the same total number of exposure exercises. Both conditions will be followed by the same 4-week online program to encourage in vivo exposure tasks for both conditions. The study will be an exploratory superiority trial testing whether one of the conditions is superior to the other. The primary outcome will be the Public Speaking Anxiety Scale. Assessments will take place pretreatment, at the beginning of the face-to-face session, during the face-to-face session, 1 week after the last VR exposure session, at the end of 4 weeks of the online program, and at two follow-ups at 3 and 12 months after finishing the online program, or equivalent time if the online program was discontinued. Repeated measures within-between ANOVA, the reliable change index (RCI), and effect sizes will be used as statistical analyses, and intention-to-treat will be the primary analysis approach; additional per-protocol analysis will be reported. Results: The study received funding from the Research Council of Lithuania (LMTLT) in April 2023. Recruitment for the study officially started in January 2024 and was still ongoing during the submission of this paper in December 2025. As of November 2025, a total of 101 participants have completed the initial screening. The final results of the study are expected to be prepared and submitted for publication in March 2026. Conclusions: This is the protocol of a study that will explore an understudied and clinically important question that could generate preliminary evidence comparing 1-session versus 3-session VR exposure for public speaking and inform further research. However, given the small and specific sample, results would have to be confirmed in larger and more diverse samples.


  • Open Access

    One-session versus three-sessions of virtual reality exposure therapy for public speaking anxiety: a randomized controlled trial

    by Olga Zamalijeva, Karolina Petraškaitė, Goda Gegieckaitė, Tom Van Daele, Per Carlbring, Philip Lindner, Gerhard Andersson, Greta Bertulytė, Jonas Eimontas

    VR technology has been a useful tool in exposure therapy working with public speaking anxiety. The common approach to treating public speaking anxiety is a single prolonged VR exposure session, but there is still lack of consensus, whether dividing the same amount if exposure into several shorter sessions would jeopardize its efficacy. This study aims to compare the efficacy of a single extended session versus the same intervention divided into three shorter sessions of VR-based exposure intervention for public speaking anxiety.37 students (mean age 22.4, 70.3% female) participated in a two-armed parallel group randomised controlled trial. The intervention involved 9 speaking tasks that were administered in a single session or divided into 3 equal parts. Public speaking anxiety scale, Liebowitz social anxiety scale and Brief Fear of Negative Evaluation scale were used as outcome measures pre- and post-exposure. Additionally, convenience, duration, fatigue, adaptability and intensity of the intervention were evaluated.Results indicate a significant reduction in the level of public speaking anxiety and social anxiety in both groups, but no differences between intervention groups and no interaction observed between time and intervention group. Participants reported single three-hour session to be more tiring and longer compared to the same amount of exposure split into 3 sessions, but did not indicate any difference in terms of convenience, adaptability, or intensity. It can be concluded that one-session treatment can be split up into three shorter ones without compromising the efficacy of public speaking anxiety VR exposure treatment.

  • Open Access

    One-Session Versus Three-Sessions of Virtual Reality Exposure Therapy for Public Speaking Anxiety: Study Protocol of a Randomized Controlled Trial (Preprint)

    by Goda Gegieckaitė, Olga Zamalijeva, Karolina Petraškaitė, Egle Nagevice, Philip Lindner, Per Carlbring, Tom Van Daele, Gerhard Andersson, Jonas Eimontas

    BACKGROUND A single session of VR exposure for public speaking anxiety has been found to be effective in reducing public speaking anxiety. Previous meta-analysis comparing one session to several sessions of in vivo exposure for specific phobias did not find a difference in effectiveness. However, because of the specificity of VR exposure and public speaking anxiety, it is unclear how dividing the same amount of exposure tasks into three shorter sessions instead of a single long one, would affect the effectiveness of VR exposure for public speaking. OBJECTIVE The aim of this study is to compare the efficacy of a VR exposure-based intervention for public speaking anxiety and the level of VR presence between a single-session condition and an equal exposure time divided into three sessions, followed by four weeks of online intervention in both groups. METHODS This randomized controlled trial will aim to recruit 86 bachelor’s students experiencing high levels of public speaking anxiety, that are randomized into one of two conditions: either one or three sessions of VR exposure therapy with the same total number of exposure exercises. Both conditions will be followed by the same four-week internet program to encourage in vivo exposure tasks for both conditions. The primary outcome will be the Public Speaking Anxiety Scale. Assessments will take place pre-treatment, at the beginning of the face-to-face session and during the face-to-face sessions, one week after the last VR exposure session, at the end of four weeks of the internet program, and at two follow-ups at 3 and 12 months after finishing the online program or equivalent time if the online program was discontinued. Repeated Measures Within-Between ANOVA, the Reliable Change Index (RCI) and effect sizes will be used as statistical analysis and intention-to-treat will be the primary analysis approach, additional per-protocol analysis will be reported. RESULTS Participant recruitment is currently ongoing. The recruitment to the study officially started in January 2024. As of November 2025, a total of 101 participants have completed the initial screening. The final results of the study are expected to be prepared and submitted for publication in March 2026. CONCLUSIONS The results of this study could give insight to practitioners and researchers on how to organize VR exposure for public speaking anxiety. Comparing three VR exposure sessions to single session exposure will contribute evidence in choosing one or other modality of intervention for the future research and clinical practice. CLINICALTRIAL ClinicalTrials.gov NCT06214039; https://clinicaltrials.gov/study/NCT06214039

  • Psychometric properties of the Lithuanian versions of the Revised Collett-Lester Fear of Death Scale and the Existential Death Anxiety Scale

    by Goda Gegieckaitė, Olga Zamalijeva, Karolina Petraškaitė, Jonathan Lewis-Jong, David Lester

    Two death anxiety measures-the Revised Collett-Lester Fear of Death Scale (CLFODS) and the Existential Death Anxiety Scale (EDAS)-facilitate the study of specific aspects of death anxiety. The aim of the present study was to test the psychometric properties of Lithuanian versions of the CLFODS and the EDAS. The sample consisted of 528 participants, 75.9% were women, from 18 to 82 years old (M = 33.63, SD = 14.47). Both scales had good psychometric properties and, for the most part, the findings confirmed the original factor structure. Confirmatory factor analyses confirmed the four-factor structure of the CLFODS and the two-factor structure of the EDAS. Both scales had good internal consistency. The results indicate that the Lithuanian versions of the CLFODS and the EDAS have good psychometric properties and can be used for research, although the EDAS factor structure might require further examination in future studies.


  • Mąstymo sutrikimo raiška psichikos sutrikimų atveju: ryšiai su pažintinėmis funkcijomis ir emocinėmis būsenomis

    by Karolina Petraškaitė

    Thought disorder symptoms in psychiatric disorders: relations with cognitive functions and emotional states

  • Open Access

    Beck Scales (BDI-II, BAI, BHS, BSS, and CBOCI): Clinical and Normative Samples’ Comparison and Determination of Clinically Relevant Cutoffs

    by Neringa Grigutytė, Vita Mikuličiūtė, Karolina Petraškaitė, Antanas Kairys

    This article aims to evaluate 5 Beck scales – Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Beck Hopelessness Scale (BHS), Beck Suicidal Ideation Scale (BSS), and Clark–Beck Obsession-Compulsion Inventory (CBOCI) – comparing clinical and normative samples, and to determine clinically relevant cutoffs. The clinical sample consisted of 242 persons aged 18–74; 39 percent were men and 61 percent were women. The normative sample consisted of 1296 persons aged 18–95; 44 percent were men and 56 percent were women. In order to compare the estimates of the normative and clinical samples of the Beck scales, a paired data study sample was formed – 230 participants from the clinical and normative groups each. The clinical sample was divided into four groups according to the primary diagnoses: 107 (46.5%) patients were diagnosed with mood (affective) disorder (F30–F39), 38 (16.5%) with neurophysical stress and somatoform disorders (F40–F49), 51 (22.2%) with disorders due to the use of psychoactive substances (F10–F19), 34 (14.8%) with high risk of suicide (X60–X84; Z91.5; R45.81). 27 percent of patients had comorbid diagnoses. The results show high internal consistency of the Beck scales in all samples. The discrimination abilities of all five Beck scales are good; the cutoffs for each Beck scale in four clinical groups are estimated. Both the total clinical sample and the 4 clinical sample groups had significantly higher BDI-II, BAI, BHS, BSS, and CBOCI scores than the normative sample. In conclusion, the Beck scales alone are not sufficient for making a decision about the clinical diagnosis.


  • Open Access

    Development and Validation Regarding the Lithuanian Version of the Positive and Negative Affect Schedule (PANAS-X)

    by Karolina Petraškaitė, Neringa Grigutytė

    Introduction: The Positive and Negative Affect Schedule (PANAS-X), a widely used and accepted instrument developed to assess multidimensional emotional experience, is used in various social and clinical settings. It has an underlying hierarchical structure of the higher order for the positive affect (PA) and negative affect (NA), and the lower order discrete affect scales that describe specific emotions; however, very little is known about the psychometric properties that this version of the instrument has. Aims: This study aims to investigate the psychometric properties in the Lithuanian version of PANAS-X, including the analysis for the factor structure of the higher and lower order scales, reliability, and validity characteristics. Methods: The study includes a demographically representative Lithuanian sample (N = 322, with an average age of 37.34, SD = 12.50). For the psychometric evaluation of the PANAS-X, researchers performed item analysis, reliability, convergent-discriminant validity, and confirmatory factor analysis. Results: The confirmatory factor analysis results support the basic structure of the PANAS-X PA, NA, and the discrete affect scales, although some scales were modified according to the item characteristics. The convergent validity is confirmed by the relations of the PA and NA as well as the discrete affect scales to the related constructs, which include personality traits, general, and psychological well-being. Conclusions: The Lithuanian version of PANAS-X can be considered a reliable and valid instrument for structuring positive, negative, and specific emotional experiences.